2Cornet AD,Smit EG, Beishuizen A, et al. The role of heparin and allied compounds in the treatment of sepsis[J]. Thromb Haemost,2007,98(3):579- 586.
3Bauer I, Bauer M, Raddatz A, et al. Influence of gender on stimulated cytokine response in patients of severe sepsis[J]. Anaesthesist,2006,55(5) :515- 527.
4Levi M, Schultz M. The inflammation coagulation axis as an important intermediate pathway in acute lung injury[J]. Crit Care,2008,12(2):144 -147.
5Lissalde-Lavigne G, Combescure C, Muller L, et al. Simple coagulation tests improve survival prediction in patients with septic shock[J]. J Thrombo Haemost,2008,6(4) :645 -653.
3Schreyer AG, Finkenzeller T, Gessmann H, et al. Microeireulation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn's disease:first results with linear contrast harmonic imaging (CHI) [ J ]. Clin Hemorheol Microeirc , 2008, 40 (2) : 143 -155.
4Kinasewitz GT, Yan SB, Basson B,et al. Universal changes in biomakers of coagulation and inflamation occur in patients with severe sepsis, regardless of causative rnico-organism[J]. Crit Care, 2004, 8 (2) : 82-90.
6Doshi SN, Marrnur JD. Evolving role of tissue factor and its pathway inhibitor[J]. Crit Care Med, 2002, 30(5): 241-250.
7Bakhtiari K, Meijers JCM, de Jonge E, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravaseular coagulation [J]. Crit Care Med, 2004,32(12): 2416-2421.
8Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J]. Blood, 2003, 101 (10) : 3765-3777.
9Lin SM, Wang YM, Lin HC, et al. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis [J]. Crit Care Med, 2008,36 (3) : 683- 689.
10Levi M, van der Poll T, Bulter HR. Bidirectional relation between inflammation and coagulation [J]. Circulation, 2004, 109(22) : 2698-2704.
